Annual Cash & Cash Equivalents:
$1.26B+$111.00M(+9.69%)Summary
- As of today, CL annual cash & cash equivalents is $1.26 billion, with the most recent change of +$111.00 million (+9.69%) on December 31, 2024.
- During the last 3 years, CL annual cash & cash equivalents has risen by +$390.00 million (+45.03%).
- CL annual cash & cash equivalents is now -18.92% below its all-time high of $1.55 billion, reached on December 31, 2017.
Performance
CL Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$1.47B+$60.00M(+4.25%)Summary
- As of today, CL quarterly cash & cash equivalents is $1.47 billion, with the most recent change of +$60.00 million (+4.25%) on September 30, 2025.
- Over the past year, CL quarterly cash & cash equivalents has dropped by -$22.00 million (-1.47%).
- CL quarterly cash & cash equivalents is now -27.77% below its all-time high of $2.04 billion, reached on March 31, 2014.
Performance
CL Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CL Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +9.7% | -1.5% |
| 3Y3 Years | +45.0% | +28.4% |
| 5Y5 Years | +38.6% | +37.7% |
CL Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +45.0% | -1.5% | +55.0% |
| 5Y | 5-Year | at high | +45.0% | -1.5% | +70.0% |
| All-Time | All-Time | -18.9% | +2098.2% | -27.8% | +2477.9% |
CL Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $1.47B(+4.2%) |
| Jun 2025 | - | $1.41B(+7.7%) |
| Mar 2025 | - | $1.31B(+4.4%) |
| Dec 2024 | $1.26B(+9.7%) | $1.26B(-15.9%) |
| Sep 2024 | - | $1.49B(+11.9%) |
| Jun 2024 | - | $1.33B(+1.9%) |
| Mar 2024 | - | $1.31B(+14.4%) |
| Dec 2023 | $1.15B(+20.5%) | $1.15B(-4.4%) |
| Sep 2023 | - | $1.20B(+10.3%) |
| Jun 2023 | - | $1.09B(-5.0%) |
| Mar 2023 | - | $1.14B(+20.3%) |
| Dec 2022 | $950.00M(+9.7%) | $950.00M(-17.1%) |
| Sep 2022 | - | $1.15B(+17.2%) |
| Jun 2022 | - | $978.00M(+4.6%) |
| Mar 2022 | - | $935.00M(+8.0%) |
| Dec 2021 | $866.00M(-6.4%) | $866.00M(-18.1%) |
| Sep 2021 | - | $1.06B(+5.1%) |
| Jun 2021 | - | $1.01B(-4.7%) |
| Mar 2021 | - | $1.06B(+14.3%) |
| Dec 2020 | $925.00M(+2.1%) | $925.00M(-13.5%) |
| Sep 2020 | - | $1.07B(+4.6%) |
| Jun 2020 | - | $1.02B(+13.9%) |
| Mar 2020 | - | $897.00M(-1.0%) |
| Dec 2019 | $906.00M(+23.1%) | $906.00M(-14.3%) |
| Sep 2019 | - | $1.06B(+13.8%) |
| Jun 2019 | - | $929.00M(+5.6%) |
| Mar 2019 | - | $880.00M(+19.6%) |
| Dec 2018 | $736.00M(-52.5%) | $736.00M(-23.4%) |
| Sep 2018 | - | $961.00M(+4.9%) |
| Jun 2018 | - | $916.00M(+1.1%) |
| Mar 2018 | - | $906.00M(-41.5%) |
| Dec 2017 | $1.55B(+11.8%) | $1.55B(-3.3%) |
| Sep 2017 | - | $1.60B(+14.8%) |
| Jun 2017 | - | $1.40B(-4.3%) |
| Mar 2017 | - | $1.46B(+5.3%) |
| Dec 2016 | $1.39B(+34.4%) | $1.39B(-10.2%) |
| Sep 2016 | - | $1.54B(+18.9%) |
| Jun 2016 | - | $1.30B(+12.8%) |
| Mar 2016 | - | $1.15B(+7.4%) |
| Dec 2015 | $1.03B(-20.0%) | $1.07B(-32.6%) |
| Sep 2015 | - | $1.59B(+21.7%) |
| Jun 2015 | - | $1.31B(+17.9%) |
| Mar 2015 | - | $1.11B(-14.0%) |
| Dec 2014 | $1.29B(+13.6%) | $1.29B(-12.8%) |
| Sep 2014 | - | $1.48B(+12.4%) |
| Jun 2014 | - | $1.32B(-35.4%) |
| Mar 2014 | - | $2.04B(+79.6%) |
| Dec 2013 | $1.14B(+13.5%) | $1.14B(+34.6%) |
| Sep 2013 | - | $843.00M(-18.5%) |
| Jun 2013 | - | $1.03B(-3.5%) |
| Mar 2013 | - | $1.07B(+7.2%) |
| Dec 2012 | $1.00B(+5.3%) | $1.00B(+1.0%) |
| Sep 2012 | - | $990.00M(-8.4%) |
| Jun 2012 | - | $1.08B(-4.0%) |
| Mar 2012 | - | $1.13B(+18.5%) |
| Dec 2011 | $950.00M(+68.4%) | $950.00M(-6.6%) |
| Sep 2011 | - | $1.02B(+28.4%) |
| Jun 2011 | - | $792.00M(+8.6%) |
| Mar 2011 | - | $729.00M(+29.3%) |
| Dec 2010 | $564.00M(-12.0%) | $564.00M(-20.5%) |
| Sep 2010 | - | $709.00M(+16.4%) |
| Jun 2010 | - | $609.00M(+1.2%) |
| Mar 2010 | - | $602.00M(-6.1%) |
| Dec 2009 | $641.00M(+13.0%) | $641.00M(-27.6%) |
| Sep 2009 | - | $885.00M(-4.7%) |
| Jun 2009 | - | $928.50M(+27.7%) |
| Mar 2009 | - | $726.90M(+28.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $567.10M(+32.3%) | $567.10M(-13.6%) |
| Sep 2008 | - | $656.40M(+2.0%) |
| Jun 2008 | - | $643.50M(-1.9%) |
| Mar 2008 | - | $655.70M(+53.0%) |
| Dec 2007 | $428.70M(-12.4%) | $428.70M(-31.8%) |
| Sep 2007 | - | $628.40M(+14.9%) |
| Jun 2007 | - | $546.90M(+15.3%) |
| Mar 2007 | - | $474.40M(-3.1%) |
| Dec 2006 | $489.50M(+43.7%) | $489.50M(-2.7%) |
| Sep 2006 | - | $502.90M(+16.8%) |
| Jun 2006 | - | $430.40M(+12.4%) |
| Mar 2006 | - | $382.80M(+12.4%) |
| Dec 2005 | $340.70M(+6.6%) | $340.70M(-9.5%) |
| Sep 2005 | - | $376.30M(-4.0%) |
| Jun 2005 | - | $392.10M(-5.3%) |
| Mar 2005 | - | $413.90M(+80.0%) |
| Dec 2004 | $319.60M(+50.4%) | - |
| Mar 2001 | - | $229.90M(+4.3%) |
| Dec 2000 | $212.50M(-9.7%) | - |
| Sep 2000 | - | $220.50M(-7.6%) |
| Jun 2000 | - | $238.70M(+1.5%) |
| Dec 1999 | $235.20M(+20.9%) | $235.20M(-6.6%) |
| Jun 1999 | - | $251.90M(+22.8%) |
| Mar 1999 | - | $205.10M(+5.4%) |
| Dec 1998 | $194.50M(-5.3%) | $194.50M(-14.0%) |
| Sep 1998 | - | $226.10M(+11.1%) |
| Jun 1998 | - | $203.60M(-9.8%) |
| Mar 1998 | - | $225.60M(+9.9%) |
| Dec 1997 | $205.30M(-33.3%) | $205.30M(-21.3%) |
| Sep 1997 | - | $261.00M(-0.7%) |
| Jun 1997 | - | $262.90M(+22.1%) |
| Mar 1997 | - | $215.40M(-30.0%) |
| Dec 1996 | $307.80M(+47.4%) | $307.80M(-3.0%) |
| Sep 1996 | - | $317.40M(+22.3%) |
| Jun 1996 | - | $259.50M(+0.0%) |
| Mar 1996 | - | $259.40M(+24.2%) |
| Dec 1995 | $208.80M(+22.9%) | $208.80M(-6.8%) |
| Sep 1995 | - | $224.00M(+35.4%) |
| Jun 1995 | - | $165.40M(-3.6%) |
| Mar 1995 | - | $171.50M(+0.9%) |
| Dec 1994 | $169.90M(-38.5%) | $169.90M(-6.1%) |
| Sep 1994 | - | $180.90M(+18.6%) |
| Jun 1994 | - | $152.50M(+3.1%) |
| Mar 1994 | - | $147.90M(+2.6%) |
| Dec 1993 | - | $144.10M(-15.4%) |
| Sep 1993 | - | $170.30M(+12.8%) |
| Jun 1993 | - | $151.00M(-14.1%) |
| Mar 1993 | - | $175.70M(+49.0%) |
| Dec 1992 | - | $117.90M(-30.9%) |
| Sep 1992 | - | $170.50M(+0.2%) |
| Jun 1992 | - | $170.20M(-16.0%) |
| Mar 1992 | - | $202.60M(+20.2%) |
| Dec 1991 | - | $168.50M(+31.1%) |
| Sep 1991 | - | $128.50M(+2.4%) |
| Jun 1991 | - | $125.50M(-5.4%) |
| Mar 1991 | - | $132.70M(-20.3%) |
| Dec 1990 | $276.40M(-47.3%) | $166.40M(+30.6%) |
| Sep 1990 | - | $127.40M(-30.4%) |
| Jun 1990 | - | $183.10M(-23.3%) |
| Mar 1990 | - | $238.70M(-40.0%) |
| Dec 1989 | $524.19M(+817.4%) | $397.90M(+86.6%) |
| Sep 1989 | - | $213.20M(-41.7%) |
| Dec 1988 | - | $365.50M(+540.1%) |
| Dec 1987 | $57.14M(-65.4%) | $57.10M(-65.4%) |
| Dec 1986 | $165.14M(-36.4%) | $165.10M(-36.4%) |
| Dec 1985 | $259.46M(-23.6%) | $259.50M(-26.2%) |
| Dec 1984 | - | $351.70M |
| Dec 1980 | $339.43M | - |
FAQ
- What is Colgate-Palmolive Company annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Colgate-Palmolive Company?
- What is Colgate-Palmolive Company annual cash & cash equivalents year-on-year change?
- What is Colgate-Palmolive Company quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Colgate-Palmolive Company?
- What is Colgate-Palmolive Company quarterly cash & cash equivalents year-on-year change?
What is Colgate-Palmolive Company annual cash & cash equivalents?
The current annual cash & cash equivalents of CL is $1.26B
What is the all-time high annual cash & cash equivalents for Colgate-Palmolive Company?
Colgate-Palmolive Company all-time high annual cash & cash equivalents is $1.55B
What is Colgate-Palmolive Company annual cash & cash equivalents year-on-year change?
Over the past year, CL annual cash & cash equivalents has changed by +$111.00M (+9.69%)
What is Colgate-Palmolive Company quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CL is $1.47B
What is the all-time high quarterly cash & cash equivalents for Colgate-Palmolive Company?
Colgate-Palmolive Company all-time high quarterly cash & cash equivalents is $2.04B
What is Colgate-Palmolive Company quarterly cash & cash equivalents year-on-year change?
Over the past year, CL quarterly cash & cash equivalents has changed by -$22.00M (-1.47%)